Immunocore Holdings PLC (IMCR)
32.06
-0.36
(-1.11%)
USD |
NASDAQ |
Nov 21, 16:00
32.06
0.00 (0.00%)
After-Hours: 19:01
Immunocore Holdings Market Cap: 1.604B for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 1.622B |
| November 19, 2024 | 1.629B |
| November 18, 2024 | 1.554B |
| November 15, 2024 | 1.581B |
| November 14, 2024 | 1.632B |
| November 13, 2024 | 1.710B |
| November 12, 2024 | 1.689B |
| November 11, 2024 | 1.733B |
| November 08, 2024 | 1.736B |
| November 07, 2024 | 1.717B |
| November 06, 2024 | 1.677B |
| November 05, 2024 | 1.651B |
| November 04, 2024 | 1.560B |
| November 01, 2024 | 1.586B |
| October 31, 2024 | 1.543B |
| October 30, 2024 | 1.596B |
| October 29, 2024 | 1.636B |
| October 28, 2024 | 1.667B |
| October 25, 2024 | 1.641B |
| October 24, 2024 | 1.626B |
| October 23, 2024 | 1.602B |
| October 22, 2024 | 1.666B |
| October 21, 2024 | 1.666B |
| October 18, 2024 | 1.720B |
| October 17, 2024 | 1.688B |
| Date | Value |
|---|---|
| October 16, 2024 | 1.664B |
| October 15, 2024 | 1.617B |
| October 14, 2024 | 1.610B |
| October 11, 2024 | 1.555B |
| October 10, 2024 | 1.545B |
| October 09, 2024 | 1.501B |
| October 08, 2024 | 1.529B |
| October 07, 2024 | 1.538B |
| October 04, 2024 | 1.556B |
| October 03, 2024 | 1.526B |
| October 02, 2024 | 1.555B |
| October 01, 2024 | 1.561B |
| September 30, 2024 | 1.557B |
| September 27, 2024 | 1.571B |
| September 26, 2024 | 1.539B |
| September 25, 2024 | 1.534B |
| September 24, 2024 | 1.504B |
| September 23, 2024 | 1.541B |
| September 20, 2024 | 1.660B |
| September 19, 2024 | 1.711B |
| September 18, 2024 | 1.723B |
| September 17, 2024 | 1.696B |
| September 16, 2024 | 1.651B |
| September 13, 2024 | 1.678B |
| September 12, 2024 | 1.652B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
830.76M
Minimum
Jan 20 2022
3.754B
Maximum
Feb 07 2024
2.157B
Average
2.031B
Median
Market Cap Benchmarks
| Adaptimmune Therapeutics PLC | 162.23M |
| Biodexa Pharmaceuticals PLC | 2.532M |
| Verona Pharma PLC | 3.104B |
| NuCana PLC | 2.853M |
| Autolus Therapeutics PLC | 754.46M |
Market Cap Related Metrics
| PS Ratio | 5.470 |
| Price to Book Value | 4.245 |
| Price to Free Cash Flow | 81.57 |
| Price | 32.06 |
| Earnings Yield | -2.96% |